Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Is Rad51D heterozygous mutation a contraindication to postmastectomy radiation?
Answer from: Radiation Oncologist at Community Practice
BRCA1/2, PALPB2, CHEK2, and RAD50/51 mutations should not affect radiation therapy https://www.redjournal.org/article/S0360-3016(19)33530-8/fulltext
Sign In or Register to read more